Driehaus Capital Management’s Pfizer PFE Stock Holding History

Driehaus Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,436,482	Closed	-$75.3M	–	388
2022 Q2	$75.3M	Buy	1,436,482 +248,396	+21%	+$12.7M	1.22%	7
2022 Q1	$61.5M	Buy	1,188,086 +1,183,819	+27,744%	+$61.4M	0.76%	22
2021 Q4	$252K	Buy	+4,267	New	+$211K	﹤0.01%	357
2019 Q3	–	Sell	-14,695	Closed	-$604K	–	556
2019 Q2	$604K	Buy	+14,695	New	+$584K	0.02%	352
2019 Q1	–	Sell	-8,533	Closed	-$353K	–	472
2018 Q4	$353K	Sell	8,533 -103	-1%	-$4.28K	0.02%	348
2018 Q3	$361K	Buy	8,636 +444	+5%	+$17.1K	0.01%	416
2018 Q2	$282K	Sell	8,192 -4,202	-34%	-$144K	0.01%	429
2018 Q1	$417K	Buy	12,394 +278	+2%	+$9.56K	0.01%	415
2017 Q4	$416K	Hold	12,116	–	–	0.02%	427
2017 Q3	$410K	Sell	12,116 -3,796	-24%	-$122K	0.02%	413
2017 Q2	$507K	Sell	15,912 -173	-1%	-$5.46K	0.02%	408
2017 Q1	$522K	Buy	16,085 +2,131	+15%	+$67.2K	0.02%	428
2016 Q4	$430K	Buy	+13,954	New	+$426K	0.02%	437
2014 Q2	–	Sell	-257,131	Closed	-$7.84M	–	604
2014 Q1	$7.84M	Buy	+257,131	New	+$7.67M	0.25%	109

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Driehaus Capital Management's PFE Position: Q3 2022 in Review

Driehaus Capital Management sold out of Pfizer (PFE) in Q3 2022, closing a stake of 1,436,482 shares — an estimated $75.3M sold.

Driehaus Capital Management first reported a position in PFE in Q1 2014 and held it in 14 quarters. The position peaked at $75.3M in Q2 2022. 3,088 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Driehaus Capital Management reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Driehaus Capital Management sold 1,436,482 Pfizer shares in Q3 2022, an estimated $75.3M.
Driehaus Capital Management first reported a position in Pfizer in Q1 2014 and held it in 14 quarters.
Driehaus Capital Management's Pfizer position peaked at $75.3M in Q2 2022.
3,088 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.